4 products were found matching "366017-09-6"!

No results were found for the filter!
Mubritinib, Free base
Mubritinib, Free base

Item number: LKT-M8007.5

A protein kinase inhibitor. It inhibits HER2, human epidermal growth factor receptor 2 tyrosine kinase.
Keywords: TAK-165
Application: HER2 inhibitor
CAS 366017-09-6
MW: 468,47 D
From 178.00€ *
Review
Mubritinib
Mubritinib

Item number: Cay12096-5

Mubritinib is a selective inhibitor of the human epidermal growth factor receptor 2 (HER2), inhibiting HER2 phosphorylation with an IC50 value of 6 nM. It is without effect on EGFR, FGFR, PDGFR, JAK1, Src, and Blk (IC50 > 25 µM). Mubritinib inhibits the proliferation of breast, bladder, kidney, and prostate cancer...
Keywords: TAK-165, 1-[4-[4-[[2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]phenyl]butyl]-1H-1,2,3-triazole
Application: HER2 inhibitor
CAS 366017-09-6
MW: 468.5 D
From 53.00€ *
Review
Mubritinib, Free Base (1-[4-[4-[[2-[(1E)-2-[4-(Trifluoromethyl)phenyl]ethenyl]-4-oxazolyl]methoxy]ph
Mubritinib, Free Base...

Item number: M9202-50.10

Mubritinib is a potent inhibitor of the human epidermal growth factor receptor 2 (HER2) tyrosine kinase. For inhibitory testing, HER2 was expressed in the following cell types: bladder (HT1376, UMUC3, T24), kidney (ACHN), and prostate (DU145, LNCaP, LN-REC4). IC50 values for mubritinib for the bladder cancer cell...
CAS 366017-09-6
MW: 468.47
231.00€ *
Review
Mubritinib
Mubritinib

Item number: AG-CR1-3755-M005

Mubritinib (TAK-165) is a selective inhibitor of the human epidermal growth factor receptor 2 (EGFR2, HER2), inhibiting HER2 phosphorylation with an IC50 value of 6nM. It is 4000-fold selective over EGFR, FGFR, PDGFR, JAK1, Src and Blk (IC50 > 25µM). Mubritinib inhibits the proliferation of breast, bladder, kidney...
Keywords: TAK-165, TAK 165, CID 6444693
Application: Antineoplastic, Receptor tyrosine kinase inhibitor
CAS 366017-09-6
MW: 468.5 D
From 33.00€ *
Review